Scheme of Rashtriya Arogya Nidhi (RAN) will have three ...
Post on 23-Mar-2023
0 Views
Preview:
Transcript
No. W. 11036139 1201 7-RANGovernment of India
Ministry of Health and Family Welfare
Department of Health & Family Welfare+>Fr<**
New Delhi, dated the Itt February, 2019.
Office Memorandum
Subject: Guidelines regarding implementation of Umbrella Scheme of Rashtriya Arogya Nidhi
(RAN).
The undersigned is directed to say that Rashtriya Arogya Nidhi (RAN) Society was set
up in 1997 to provide financial assistance to patients, living below poverty line and who are
suffering from major life threatening diseases, to receive medical treatment at any of the super
specialty Govemment hospitals / institutes. In its meeting held on 7.8.2018, the Managing
Committee of the RAN Society has decided, inter alia, that the Society shall be closed w.e.f.
1.1.2019. Accordingly the function of the RAN Society will now vest in the Department of Health
and Family Welfare w.e.f. 1.1.2019 and RAN scheme including Health Minister's Cancer Patients
Fund will be implemented by the Department of Health and Family Welfare.
2. To provide financial assistance to poor patients a new Umbrella Scheme of Rashtriya
Arogya Nidhi has been formulated with the approval of the competent authority. The Umbrella
Scheme of Rashtriya Arogya Nidhi (RAN) will have three components namely (i) Rashtriya
Arogya Nidhi (RAN), (ii) Health Minister's Cancer Patients Fund (HMCPF) and (iii) Scheme for
financial assistance for patients suffering from specified rare diseases. A copy ofguidelines ofthe
new Umbrella Scheme is enclosed for information and necessary action.
4uUnder secretary to the o",.Jti/Y1tr'
Tel: 23061986
To
1. All the Govemment hospitals (as per list enclosed).
2. All Regional Cancer Centres (as per list enclosed).
3. All State Cancer Institutes and Tertiary Cancer Care Centres (As per list enclosed).
. 4. Health Secretaries of all State Govemments/UT Administrations.
Copy to:
1. Finance Division.2. Under Secretary (PH/RD).3. Director (Budget).
Copy for information to :
l. PS to HFM.2. PS to MoS (AKC).3. PS ro MoS (AP).4. Sr. PPS to SecretarY (HFW).5. Sr. PS to AS&FA.6. Sr. PS to AS (Health).
7. Sr. PS to AS&MD.8. PS to Addl. DG (AKG).9. Sr. PS to JS (Rare Diseases).
10. Sr. PS to EA (NS).11. PS to CCA.12. Addl. DDG (BRS).
0v,*.r.d",V-
Under Secretary to the Govemment of IffiTel:23061986
tation o
(RAN).
The umbrella scheme of Rashtriya Arogya Nidhi (RAN) will have three components
namely (i) Rashtriya Arogya Nidhi (RAN), (ii) Health Minister's cancer Patients Fund (HMCPF)
and (iii) Scheme for financial assistance for patients suffering from specified rare diseases'
2. The objectives of the three components of the RAN Scheme are given below:
(a) Rashtriya ArogyaNidhi- to provide financial assistance to poor patients living
below threshold poverty line and suffering from life threatening diseases relating to
heart, kidney, liver, etc for their treatment at Government hospitals/institutes having
super sPecialtY facilities.
(b) Heatth Ministerrs Cancer Patient Fund - to provide financial assistance to poor
patients living below threshold poverty line and suffering from cancer' for their
treatment at Regional Cancer Centres (RCCs)iTertiary Care Cancer Centres (TCCC)
and State Cancer Institutes (SCD.
(c) Financial assistance Scheme for poor patients suffering from rare diseases - to
provide financial assistance to poor patients living below threshold poverty line and
suffering from specified lare diseases for their treatment at Govemment
hospitals/institutes having super specialty facilities'
3. Details of guidelines and procedures for implementation of the Umbrella Scheme of RAN
are as under.
4. General conditions governing the Umbrella Scheme of RAN are as under:
(i) Financial assistance will be provided to poor patients living below StateAJT-wise
threshold poverty line as per Annexure-I'
(ii) List of diseases covered for financial assistance under the Umbrella Scheme of RAN is at
Annexure-Il.
(iiD patients will be provided financial assistance for their treatment at Government hospitals
having super specialty facitities. Those having treatment in private hospitals will not be eligible
for financial assistance under the scheme'
(iv) The financial assistance to eligible patients wilt be in the form of 'one-time grant''
(v) Government servants and their families will not be eligible under this scheme'
(vi) There will be no reimbursement of expenditure already incurred'
Lq-t- 'l "9------"---u(4
aN
(vii) Families covered under Ayusman Bharat - Pradhan Mantri Jan Arogya Jojna (PMJAY)
will not be etigible for financial assistance under RAN and HMCPF components'
(viii) In a bid to speed up the assistance to the needy patients, Revolving Funds are set up in
Govemment Hospitals/Institutes listed at Annexure-Ill. Funds up to Rs. one crore for each
component separately (Rs. two crore in case of AIIMS, New Delhi for RAN component only) will
be placed at their disPosal.
(ix) Powers are delegated to the Medical Superintendent/Director of the hospitals with
revolving funds for providing treatment up to Rs. 5 lakh for eligible patients in each case, out of
revolving fund.
(x) More hospitals shall be added in the list of hospitals with revolving fund as and when such
hospitals are identified by the Technical Committee.
(xi) Cases involving treatment beyond Rs. 5
cases for financial assistance from hospitals
lakh in hospitals with revolving fund and all the
not having revolving fund will be referred to
Department of Health & Family Welfare, Govemment of India for approval'
(xii) Funds shall be released to hospitals not having revolving fund in respect of cases approved
by the Department of Health and Family Welfare along with the sanction letter'
(xiii) No separate funds will, however, be released to hospitals having revolving funds in respect
of cases received in and approved by Department of Health and Family welfare, involving
treatment beyond 5 lakh and such expenditure will be met out of the revolving funds.
(xiv) In case of hospitals having revolving fund, the cost of treatment in ail eligible cases will be
met out of the revolving fund, which will be replenished from time to time, on the basis of
utilization certihcate and list of beneficiaries furnished by the hospitals. On utilization of 7 5%o of
the amount placed in revolving fund, hospitals will become eligible for replenishment.
(xv) Maximum financial assistance admissible under the Scheme will be Rs. 15 lakh.
(xvi) Financial assistance received under Prime Minister's National Reiief Fund (PMNM) or
from any other source by the patient for treatment, shall be deducted from the admissible amount of
financial assistance under the Umbrella Scheme of RAN.
(xvii) For RAN and HMCPF components, there will be a Technical Committee, which shall
advise the Govemment in technical matters such as enlisting of diseases covered under Umbrella
Scheme of RAN and identifi,ing Govemment hospitals/institutes for setting up of revolving funds'
examining requests for financial assistance received in the pepartment and giving their
-2- n "L-
recommendations on any other matter of techlical nature'
Committee will be as under:
The composition of the Technical
1. Addl. DGiAdviser, DGHS.
2. Joint Secretary/Economic Adviser concerned'
3. Medical Superintendent, Dr. RML Hospital, New Delhi'
4. HOD, CardiologY, AIIMS, New Delhi'5. HOD, Haematology, AIIMS, New Delhi'
6. HOD, Medical Oncology, Safdarjung Hospital, New Delhi
(xviii) Experts in rare diseases will be associated with the above Technical Committee to
advise the Government in matter listed at sub para xvii above, in respect ofrare diseases.
5. Conditions specific to Scheme for financial assistance for patients suffering from specified rare
diseases
(i) The objective of this comporent is to provide financial assistance to poor patients living
below StatefuT-wise threshold poverty line (Annexure-I) and suffering from specified Rare
Diseases (Annexure-Il), to begin with, for their treatment at Government hospitals having super
specialty facilities.
(ii) The rare diseases specified in Annexure-Il are disorders identified based on availability of
treatment, reasonably proven clinical outcomes and cost effectiveness. The list of specified rare
diseases for financial assistance under Rare Diseases component of Umbrella Scheme of RAN will
be as suggested by the relevant Technical Committee.
(iiO Patients suffering from rare diseases as specified in Annexure-Il belonging to the socio-
economic categories that are eligible to be PMJAY beneficiaries will also be considered for
packages not covered under PMJAY.
6. Common application form has been prescribed (Annexure-IV) for submission ofrequest for
financial assistance under any of the component of the Umbrella Scheme of RAN. The application
shall be signed by the treating doctor/Head of the Department and countersigned by the Medical
Superintendent of the hospital concemed.
7. Application for financial assistance shall be submitted along with:
(D Income certificate (in originat) of the patienvparents/other major eaming members of the
family, indicating income from all sources, duly certified by the Block/Mandal Development
officer/Tehsildar/SDM/ Administrator/special officer of Municipal Boards/District officer'
(ii) A copy of the entire ration card along with its cover page, with details of all the family
members, issued by the Food and civil Supplies Department of the stateruT Govemment duly self
attested.
g. All Govemment hospitals, where revolving funds are set up under RAN as well as Rare
Diseases components, will open separate bank accounts for the two sub components and submit the
-z' L\"*---"-
bank details to the Ministry immediately so that funds could be transferred to them under the
Umbrella Scheme of RAN.
g. Similarty all27 Regional Cancer Centres, where revolving funds are set up under HMCPF
component, will open a separate bank account for the purpose and submit the bank details to the
Ministry immediately so that funds could be transferred to them under the Umbrella Scheme of
RAN.
10. This has approval of the competent authority.
Enc: Annexure I to IV.
\t-"'(i
4-
Annexure-I
Rural and Urban w.e.f.
In Rupees
For Andaman Nicobar Islands use threshold levels of TarnilNadu, for Dadra and Nagar Haveli and forDaman and Diu use levels for Gujarat, and for Lakshadweep use levels for Kerala, for Chandigarh use
levels for Punjab.
State/UT
Per capita per month poverty line as
fixed by erstwhile PlanningCommission for 20tl-12
Revised per capita threshold income permonth w.e.f. 1.1.2019 under UmbrellaScheme of Rashtriya ArgYa Nidhi
Rural Urban Rural Urban
ALL India 816 1000 1 160 r388
Andhra Pradesh 860 1009 I191 1529
Arunachal Pradesh 930 r060 t49s I 701
Assam 828 l 008 1 190 l 387
Bihar 778 923 1134 1269
Chhattissarh 738 849 1064 I 185
Delhi I145 lt34 t57t 1605
Goa 1 090 r134 l 668 r522
Guiarat 932 t1s2 1327 1 530
Haryana 1015 1169 1902 I 593
Himachal Pradesh 913 1064 1239 1467
J&K 891 988 1339 1391
Jharkhand 748 974 l 09s 1349
Karnataka 902 1089 r294 I 578
Kerala 1018 987 1484 1425
Maharashtra 967 1126 13 88 1484
Madhya Pradesh 771 897 1047 l 258
Manipur 1118 I 170 1850 r629
Meghalaya 888 1 154 1248 1 536
Mizoram l 066 l 155 1488 1 500
Nasaland t210 1302 1916 1 808
Odisha 69s 861 1011 1 180
Puducherry 1301 I 309 1881 1 838
Puniab I 054 I 155 147 5 r563
Raiasthan 905 1 002 1272 1411
Sikkim 930 1226 t407 1 808
TamilNadu 880 937 1266 r33I
Telangana 860 l 009 1264 r 395
Tripura 798 920 1191 1334
Uttar Pradesh 768 941 1061 1327
'Uttarakhand 880 1 082 1208 141 5
West Bengal 783 981 1138 1 368
5- t>
Annexure-II
Illustrative list of categories of treatment for financial assistance under RAN component
(T'his list is reviewed by the Technical Committee fiorn time to time )
1. Cardiolog-r'& Cardiac SurgerY:
I ) Pacemakers including cRT/Biventricular pacemaker
Z) Automatic lnplantaLle Caldiovertel Defibrillator (AICD) and Cornbo
clevices.
3) Co1o1ary Artery Disease including Diagnostic Clardiac Clatheterization and
Coronary AngiograPhY.
4) lnteruentional procedure including Angioplasty. with or *'ithout Stents
(Bare rnetal Stents as rvell as Drug Eluting Stents) Rota-ablation, Balloon
Valvuloplasty.5) ASD. VSD and PDA device closure'
6) peripheral Vascular Angioplasty including Carotid Angioplasty & Renal
Angioplasty, Aortic Surgery and Stent Grafting'
7) Coil Ernbolization and Vascular plugs'g) Electrophysiological Studies (EPS) and Radio Frequency (RF) Ablation.
9) Cardio vascular sllrgery for Congenital and Acquired conditions
including C.A.B.G, Valve replacement etc.
10) Heart/Lung Transplantation.(ceiling cost may be upto CGHS rates)
11) Intra Aortic Balloon Pump flARP)'l2jThrombolytic Thelapy for Acute Myocardial Infarction, Pulrnonary
Thromboembolism & Pro sthetic t'ah'e Thrombo sis'
13)IVC Filter
2. Cancer:
1) Radiation treatment of all kinils including Radio Ther:apy and
Gama Knife Surgery/GRTiMRT/Brach-r'therapy'
2) Anti-Calcer Chemotherapy r.vith supportive rnedication including
homronal therapy.
3 ) Bo1e Marrorv Transplantation- Allo,genic& Autologolls
4) Diagnostic Procedures- including PET scatt'
5) Surgery for operable malignant tumours'
3. Urologr,/1.{errhrology/Gastroenterologv/GI Surgetry :
1)Dialysis(BothHaenrodialysisaswellasPeritoneal)2) Plasrnalpheresis in ABO incompatible douors
3) Continuous RRT in Acute Renal failure
4) Vasculal-access consumables (AV Grafts, Catheters includirrg perm
catheters) for DialYsis'5) Renal transplant-The ceiling cost nlay be upto GGHS rates.
6) USG guided PCNL and USG guided SPC'
Zj Uraooopic surgical procedures in urology inclucling CPE rvith
TURBT.CP-E with endoscopic catheterization, CPE witli clot evacuation.
8) Endoscopic strrgical procedures in Gi surgery'
9) Acute GI energelcies like Acute Pancreatitis. GI bleeding, Cholangitis,
peritonitis, Intestinal Obstruction, Biliar,v stricture. Acute Fulminant Hepatitis'
Hepatic Encephalopathy, Hepatic Abscess etc'
t 0j Liver Transplantation and Surgery for portal
may be upto CGHS rates.
- G-
hypertension- the ceiling cost
?, M
^{ {,r+ -----
4. Orthorredics:
1) Treatment of Trar-tmatic & Pathological Ftacture'*
2) Implants for joint replacement'{'+
3) Spinal tixatior-r implant.**
'konly Indigenous iniplar:rts for use in Fracture and Poly Trauma will be
permitted under the scheme.
*,FJustification for Non Indigenous Lnplants tvould be provided by the treating
doctor.
5. NeurosurgelT - Neurologl' :
1) Brain Tumours2) Head injurY3) Intracranial aneurysms & aneurysms of *'eek vessels.
4) Vascular Malfonnations of brain & spinal cord
5) SPinal Tumors6) Degelerative iDern-velinating diseases of brain/spinal cord
7) CerebrosPinal Stroke
8) Status EPilePtics9) Ivlovement Disorders1 0) Neurological infections (Acute/chronic)
1 1) Traumatic SPinal InjurY12) Occlusive Vascular Disease of Brain
1 3) Guillain-barre syndrome14)MyastlreniaGravisinCrisis(rrredicalandsurgical)1 5) Acute Po lymyo sitiswithVentilatory Failure
16) Acute or Clu'oriic Autoimmune' Diseases
6. Endocrinologl' :
1) Complications and sequel of diabetes i.vhich require one time treaflnent e.g'
Amputation or Renal Tlansplant or Retinal detachment, Glaucotra etc..
2) GH deticiencY3) Adrenal insufficiency (Acute/Chr:onic)
4) Cushing's Disease
5) E,docrine surgery rvith post surgical treatment tbr one year.
6) Metabolic Bone Disease/Renal Tubular Acidosis'
7. Mental Illness :
Any treatment requiring one time grant for melltal disorders including
1) Organic Psychosis (actrte/ chlonic)'Z) Functionai psychosis i,cludi,g Schizoptu'enia. Bio-polar
Disorders, delusional disorclers and other acute polyrnorphic psychosis
Severe OCD. Son.iatoform disorders'
Develgpmer-rtal disor:clers ilcigdilg Autisl-r spectrum disorders and Severe))4)
Selyiviolal disorders during childhood.
ilrr" or"g;;*";,,r".,roir,u.hological assessments. IQ assesstnent, blood
tests like ,"ru,, Iithiurn ancl drug level of carbarnazepiue, valporate'
pherrytoin ancl any other similar meclications'
6) CStr studies screening lor substances abuse/toxicology'W
8. Gynecologl':
uterine Arter.y Ernbolization tbl Post Patlum Flemorhage
9 Rarc Diseascs :
1. Disorders amenable to treatment with Hematopoietic Stem Cell
Transplantation (HSCT)
i. Lysosomal storage disorders in early stages for which Enzyme replacement
Therapy (ERT) i"s presently not avaiiable leg Metachromatic Leukodystrophy'
Krabbe,s disease *d ,.r.r. form of Mucopolysaccharoidosis (MPS) type I
within first 2 Years of age.
ii. Adrenoleukodystrophylearly stages), before the onset of hard neurological signs'
iii. Immune deficiency aisoroerr "g-
S.r.r. Combined Immunodeficiency (SCID)'
chronic Granulomatous disease, wiskot Aldrich syndrome,etc
iv. Osteopetrosisv. Fanconi Anemiavi. Others to be decided on case to case basis
2. Disorders amenable to organ transplantation
i. Liver Transplantation -Metabolic Liver diseases and other Inborn Errors of
Metabolism (small molecule diseases)
i. Tyrosinemia (failure to respond io nitisinone therapy or have documented
evidence of malignant changes in hepatic tissue)
ii. Glycogen storag"e disorderi (GSD' I, III and IV due to poor metabolic
control, multiplJ liver adenomas, or high risk for Hepatocellualr carcinoma
or evidence of substantial cirhosis or liver dysfunction or progressive liver
failure,iii. MSUD (Maple Syrup Urine Disease),
iv. Urea cYcle disorders,v. Organic acidemias,vi. Wilson's disease (Decompensated cirrhosis)
vii. Bile acid synthetic defects (Decompensated cirrhosis)
viii. CriglerNajjar TYPe 1,
ix. Alpha t antitrypiin deficiency (Decompensated cirrhosis)
x. Progressive -famitial
Intrahepatic cholestasis (PFlC)(Decompensated
cinhosis)xi. Others to be decided - case to case basis
ii. Renal TransPlantation-i. FabrY's disease,
ii.AutosomalrecessivePolycysticKidneyDisease(ARPKD),iii. Autosomal dominant poiyrystic Kidney Disease (ADPKD)
iv. Others on case to case basis
iii) Patients requiring combined liver and kidney transplants -Rarely Methyl
Malonic aciduria may require combined liver & Kidney transplant) etc
10. Miscellaneous :
Any life saving procedr.rre/ any other major illness/tleatment/inter-ventiotl not
covered uder- any of the components ot: Umbrella Scheme of IIAN and recomme'ded by
the Tec.hnical Committee cotrlcl be consider:ed lbr financial assistallce '
- 8, !' Y-,
Annexure-III
1. AIIMS, NewDelhi2. Dr. RML Hospital, New Delhi3. Safdarjung Hospital, New Delhi.4. Lady Hardinge Medical College & Smt. SK Hospital, New Delhi'
5. PGI, Chandigarh6. JIPMER, Pudducherry7. NIMHANS, Bangalore8. SGPGIMS, Lucknow9. CNCI, Kolkata10. KGMC, Lucknow11. NEIGRIHMS, Shillong12. RIMS, Imphal.13. SKIMS. Srinagar.14. Sree Chitra Tirunal Institute of Medical sciences and Technology, Thiruvananthapuram.
Diseases comoonents of the Umbretla Scheme of RAN
1.
2.
3.4.
5.
comDonent
Kamala Nehru Memorial Hospital, Allahabad, Uttar Pradesh'
Chittaranjan National Cancer Institute, Kolkata, West Bengal
Kidwai Memorial Institute of Oncology, Bangalore, Kamataka'(SCD
Regional Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu' (SCI)
Acf,aryaHarihar Regional Cancer, Centre for Cancer Research & Treatment'
Cuttack, Orissa.(SCI)6. Regional Cancer Control Society, Shimla, Himachal Pradesh'
7. Caicer Hospital & Research Centre, Gwalior, Madhya Pradesh'
8. Dr. B.R.A. indian Rotary Cancer Institute, (AIIMS), New Delhi'
9. R.S.T. Hospital & Research Centre, Nagpur, Maharashtra'(TCCC)
10. Pt. J.N.M. Medical College, Raipur, Chhatisgarh'
I i. Post Graduate Institute of Medi"al Education & Research (PGlMER),chandigarh.
12. Sherl- Kashmir Institute of Medical Sciences, Soura, Srinagar'
13. Regional Institute of Medical Sciences, Manipur, Imphal'
14. Govt. Medical College & Associated Hospital, Bakshi Nagar, Jammu'
15. Regional Cancer Centre, Thiruvananthapuram, Kerala
16. Gujarat Cancer Research Institute, Ahmadabad, Guj arat'
17. MNJ lnstitute of Oncology, Hyderabad, Andhra Pradesh' (SCI)
18. Pondicherry Regional Cancer Society, JIPMER, Pondicherry'
19. Dr. B.B. Cancer Institute, Guwahati, Assam.
20. Tata Memorial Hospital, Mumbai, Maharashtra
21.Indira Gandhi Institute of Medical Sciences, Patna, Bihar' (SCI)
ii. e"fr*V"frfti Regional Cancer Trust & Research Institute (RCC)'
Bikaner,Raj ashtan.
23. Regional iancer centre, pt. B.D.Sharma post Graduate Institute of Medical
Sciences, Rohtak, HarYana.
24. Civil Hospital, Aizawl, Mizoram. (TCCC)
iS. S*;uy C*ani Post Graduate Institute of Medical Sciences, Lucknow' (TCCC)
26. Govemment Arignar Anna Memorial Cancer Hospital, Kancheepuram'Tamil Nadu'
27. Cancer Hospital, Tripura, Agartala.(SCl)
-9- +Y"
Annexure-fV
ffiScRT,TtoNARYGRANTSRashtriya ArogyaNidhi
U*ttt, Uinister's Cancer Patient Fund
Rare Diseases
Minister's Discretionarv Grant ([IMDG)(Please tick rnark (,i )
Na,ne of tne Patient (in Block Letters)
@-ernlanent Address along with Pin Code
(b) Address for corresPondence
(a) grnait Aadress (if available)
(b) Mobile No. (if available)
(a) Father's /Mother's name
(b) Husband/wife's name
Appticalrt's R"tattorship with the Patient
ffig (Nameofthedisease)
n whom the Patient
is dependent, is uu employee of Centre/State Government
N ll.familY members
from all sources issued by Tehsildar/BDO/SDO/
SDM/DC.(Original lncome Certificate should be attached'
Ho*-.u.r, where online certificates are issued' self
attested coPY of inco
ffissistance required
ffis been received from (a)
any Ministry/Depaftment other t!a1 ftinisly :f H,"{ll,tful,"ify Weifare^such as Prime Minister National Relief
Fund or CM Relief Fund for treatment of the same
disease.
elfare earlier' Ifso' full
details rnay be given.
ffitheRationcard
- to -
I
2 Age
)
4
5
6
7
8
9
10
11
12
ffi (Attach self attested coPY)
authentication with tIP4l.
I hereby share my Aadhaar Nutnber issued by UIDAI &
voluntaiily give my consent to link rny Aadhaar Nurnber
with my request for financial assistance under
RAN/HMCPF/Rare Disease/HMDG Schernes' I also
authorize Ministry of Health & Farnily Welfare to use my
AuJnuu, card details & identity information for
DECLARATION
L l declare that the information given above is correct and complete in all respect'
2. I am not covered for benefits under Pradhan Mantri Jan Arogya Yojna (PMJAY)'
OR(For rare diseases)
Though I am covered under pMJAy, the amount of financial assistance required, indicated at colurnn 10
above, is only for packages not covered under PMJAY'
Signature of the ApplicanVPatientDate :
ToBEFILLEDBYTHEM.o.INCI{ARGBoFTIIECASE/HoSPITALiETC!WHERETHE
-PATIENT IS RECEIV[NG
1. Name of the Patient & Hospital Registration No'
2. Gist of Reports of important Investigations done
3. Diaguosis-A short Note on the present clinical
conditions rnaY be indicated
4. Ifthe patient has been operated, please
lndicate the date ofoPeration
5.(a)The name of the Hospital where the patient is
receiving treatment.
(b) Whether Hospital is Government or Private'
6. Arrount recommended for treatment
7. Probable date of operationiintervention
- lt-p,uU ,{vr-.-
8. Item wise break up of expenditure recommended in Column 6
Cost (In RuPees)"a for
g.CertifiedthatthepatientisnotcoveredforbenefitsunderPMJAY.
OR
(For rare diseases)
For patients covered under PMJAY, the amount recommended for treatment under column 6 above' is only
fr packages not covered under PMJAY'
1.
2.
Signature of the HOD/MO-in-charge
(Note below the level of consultant/Asiistant Professor with offrcial Seal
certified that the patient,s particulars given above are true to the best of my knowledge and belief'
Details of Bank account (including IFSC Code) of the hospital to.which funds are to be transferred
(Bank details are to be provided in cases "f
1;;p't"it'wtreie revolving funds have not been set up)'
Signature of the Medical Superint"l*nl?lth"girpl"VVfedical Institution with Offi cial Seal
tttl" Bank & Address
PAN/TIN/TAN
Dfrilffif tlre a"count holder- name of
- tz- Pt>
top related